Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;1462(1):27-36.
doi: 10.1111/nyas.14243. Epub 2019 Oct 26.

Adult stem cells and regenerative medicine-a symposium report

Affiliations
Review

Adult stem cells and regenerative medicine-a symposium report

Jennifer Cable et al. Ann N Y Acad Sci. 2020 Feb.

Abstract

Adult stem cells are rare, undifferentiated cells found in all tissues of the body. Although normally kept in a quiescent, nondividing state, these cells can proliferate and differentiate to replace naturally dying cells within their tissue and to repair its wounds in response to injury. Due to their proliferative nature and ability to regenerate tissue, adult stem cells have the potential to treat a variety of degenerative diseases as well as aging. In addition, since stem cells are often thought to be the source of malignant tumors, understanding the mechanisms that keep their proliferative abilities in check can pave the way for new cancer therapies. While adult stem cells have had limited practical and clinical applications to date, several clinical trials of stem cell-based therapies are underway. This report details recent research presented at the New York Academy of Sciences on March 14, 2019 on understanding the factors that regulate stem cell activity and differentiation, with the hope of translating these findings into the clinic.

Keywords: adult stem cells; age-related degeneration; aging; differentiation; epidermal stem cells; hematopoietic stem cells; immune-stem cell interactions; inflammation; lung stem cells; mesenchymal cells; muscle stem cells; regenerative medicine; stem cell niche; stem cell signaling; tissue regeneration; tumor stem cells.

PubMed Disclaimer

Conflict of interest statement

Competing interests

The authors declare no competing interests.

References

    1. National Cancer Institute. 2005. Blood-forming stem cell transplants. September 9, 2005 Accessed April 17, 2019 https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant....
    1. U.S. Food and Drug Administration. 2019. Approved cellular and gene therapy products. May 24, 2019 Accessed August 28, 2019 http://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-produc....
    1. European Medicines Agency. 2018. Holoclar. September 17, 2018 Accessed April 17, 2019 https://www.ema.europa.eu/en/medicines/human/EPAR/holoclar.
    1. Beronja S, Livshits G, Williams S, et al. 2010. Rapid functional dissection of genetic networks via tissue-specific transduction and RNAi in mouse embryos. Nat. Med 16: 821–827. - PMC - PubMed
    1. Adam RC, Yang H, Rockowitz S, et al. 2015. Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice. Nature 521: 366–370. - PMC - PubMed

Publication types

LinkOut - more resources